NPI: 1346209970 · JACKSONVILLE, NC 28546 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,665 | $189K |
| 2019 | 14,759 | $142K |
| 2020 | 16,139 | $121K |
| 2021 | 13,131 | $134K |
| 2022 | 6,894 | $165K |
| 2023 | 2,482 | $145K |
| 2024 | 2,372 | $170K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,796 | 2,205 | $924K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,109 | 1,087 | $85K |
| J1756 | Injection, iron sucrose, 1 mg | 4,458 | 1,205 | $21K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,882 | 997 | $18K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 334 | 207 | $18K |
| J0636 | Injection, calcitriol, 0.1 mcg | 365 | 29 | $405.90 |
| 85041 | 1,084 | 1,015 | $0.00 | |
| 83970 | 828 | 770 | $0.00 | |
| 85048 | 1,083 | 1,014 | $0.00 | |
| 83540 | 400 | 377 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 36 | 12 | $0.00 |
| A4657 | Syringe, with or without needle, each | 1,295 | 1,217 | $0.00 |
| 83550 | 399 | 376 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 160 | 106 | $0.00 |
| 82728 | 415 | 395 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 47 | 46 | $0.00 |
| 90674 | 16 | 16 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 681 | 79 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 54 | 51 | $0.00 |